Contact this trialFirst, we need to learn more about you.
CAR T-cell Therapy
FT536 for Gynecologic Cancers
Recruiting1 awardPhase 1
Minneapolis, Minnesota
This trial is testing a new treatment called FT536 given directly into the abdomen three times a week for one week to treat recurrent gynecologic cancers. Patients will also receive a short course of chemotherapy before
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service